Choline-Geranate (CAGE) Ionic Liquids Potentiate The Anticancer Activity Of Platinum-Based Drugs

21 April 2025, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

The influence of choline and geranic acid-based ionic liquids (CAGE ILs) on the anticancer activity of selected Pt(II) and Pt(IV) complexes was investigated. All complexes exhibited appreciable solubility in CAGE ILs, with Pt(II) complexes 2 and 4 undergoing immediate ligand substitution. In contrast, the hydrophobic derivative 3 demonstrated remarkable stability for up to 48 hours. ¹⁹F-¹H HOESY NMR analysis revealed that 3 localized within the hydrophobic regions of CAGE 1:2 (choline:geranate). When tested in U87 glioblastoma cells, CAGE ILs enhanced the anticancer activity of the Pt complexes. Notably, complex 3 exhibited a significant increase in cytotoxicity, nearly completely reducing cell viability when formulated with CAGE IL.

Keywords

Pt drugs
CAGE ionic liquids

Supplementary materials

Title
Description
Actions
Title
Supporting Information
Description
Experimental details, and supplementary experimental data
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.